Ashok Raj
Pediatric Hematology-Oncology · Louisville, KYNPI 1508840034
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $106,594 of the $164,819 with a category attached, or 64.7%. 21 manufacturers reported payments, led by Pfizer at 33.1% of the total. 2025 is the largest year on record at $46,661, more than ten times the $1,790 reported in 2019.
Across 197 payments — averaging $836.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$55K
- Jazz Pharmaceuticals Inc.$50K
- Global Blood Therapeutics, Inc.$24K
- Sanofi$9K
- Sobi, Inc$8K
- USWM, LLC$7K
- plus $13K from 15 others
Across 190 payments — averaging $4953.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Jazz Pharmaceuticals Inc.$621K
- Merck$88K
- Pfizer$81K
- AbbVie$63K
- Novartis$33K
- E.r. Squibb & Sons, L.L.C.$24K
- plus $31K from 3 others
What the payments were for
- Consulting fees$33,96221%
- Speaking & faculty fees$106,59465%
- Travel & lodging$16,94610%
- Food & beverage$7,3054%
- Education$110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 62 | $54,591 |
| Jazz Pharmaceuticals Inc. | 33 | $49,709 |
| Global Blood Therapeutics, Inc. | 18 | $23,845 |
| Sanofi | 14 | $8,922 |
| Sobi, Inc | 9 | $7,561 |
| USWM, LLC | 5 | $7,316 |
| Genentech USA, Inc. | 8 | $5,612 |
| Terumo BCT, Inc. | 2 | $2,250 |
| CSL Behring | 9 | $1,297 |
| Merck | 9 | $1,245 |
| Novartis | 6 | $896 |
| HEMA Biologics, LLC | 7 | $400 |
| Adaptive Biotechnologies Corporation | 3 | $364 |
| AstraZeneca | 2 | $246 |
| Novo Nordisk | 2 | $142 |
| Bayer | 1 | $125 |
| Amgen | 1 | $109 |
| Silk Road Medical, Inc. | 1 | $105 |
| Shire North American Group Inc | 3 | $45 |
| Servier Pharmaceuticals LLC | 1 | $24 |
| Genentech, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RYLAZE$49,503
- OXBRYTA$43,252
- HYMPAVZI$25,089
- DOPTELET$7,186
- HEMLIBRA$5,468
- Spectra Optia Apheresis System$2,250
- KEYTRUDA$931
- ADAKVEO$746
- clonoSEQ$268
- Gamifant$250
- ALTUVIIIO$244
- Kerendia$125
- ALPROLIX$120
- QFITLIA$117
- ULTOMIRIS$111
- Blincyto$109
- ENROUTE .014 Guidewire$105
- ENROUTE Transcarotid Stent$105
- ENROUTE Transcarotid Neuroprotection System$105
- ENHANCE Transcarotid Peripheral Access Kit$105
How this compares
Too few pediatric hematology-oncology providers in Kentuckyto place this figure against a meaningful peer group, so we don't.
Other pediatric hematology-oncology in Louisville
- Michael FergusonLouisville$3K
- Kerry McGowanLouisville$1K
- Esther KnappLouisville$1K
- William TseLouisville$585
- Mustafa BarbourLouisville$425
- Erica MamauagLouisville$306
- Salvatore BertoloneLouisville$246
- Judith KabatLouisville$19
- Megan ScruggsLouisville$19
- Vlad RadulescuLexington$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.